President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for lowering drug costs. Trump's action didn't affect the caps on seniors' drug costs or Medicare price negotiations that Biden signed into law.

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started, so current drug prices are unaffected.

The Trump administration’s first drug pricing action — rescinding a Biden executive order encouraging Medicare to help lower prescription costs — is befuddling drug pricing experts.

Amidst political shifts, President Trump revoked a Biden-era directive aimed at reducing prescription drug costs, raising questions about future policies. Under Biden's order, the Department of Health and Human Services (HHS) was tasked with exploring ways to cut medication expenses for Medicare and Medicaid,